Bloomberg News

Roche May Abandon its Bid for Illumina, SonntagsZeitung Reports

April 01, 2012

Roche Holding AG (ROG), a Basel, Switzerland-based drugmaker, may drop its $6.6 billion bid for Illumina Inc. (ILMN:US), SonntagsZeitung reported, citing an unidentified person close to Roche’s board.

San Diego, California-based Illumina, a diagnostics company, can’t rely on Roche’s continuing participation in negotiations, the person said, adding that for Roche, Illumina is a “nice-to-have,” not a “must-have,” the Swiss newspaper reported.

To contact the reporter on this story: Leigh Baldwin in Zurich at lbaldwin3@bloomberg.net

To contact the editor responsible for this story: Mariajose Vera at mvera1@bloomberg.net


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • ILMN
    (Illumina Inc)
    • $172.26 USD
    • -5.66
    • -3.29%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus